Some Trump administration officials are growing skeptical that the Senate will confirm Heidi Overton to lead the Food and Drug Administration, prompting them to discuss whether to attempt to shore up her nomination or abandon it altogether, according to four people familiar with the matter who spoke on the condition of anonymity to discuss a personnel matter.
Leave a comment